Testing & validation of pre-clinical multispectral SPECT and simultaneous PET/MRI using silicon photomultiplier technology

测试

• 批准号: 499115-2016
• 负责人: Beyea, Steven
• 金额: $ 5.83万
• 依托单位: Dalhousie University
• 依托单位国家: 加拿大
• 项目类别: Collaborative Research and Development Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=607202
• 关键词: Testing; validation; pre; clinical; multispectral

Imaging technologies such as Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) have played an invaluable role in human imaging for many decades. More recently, there has been a resurgence in interest in so-called "hybrid" technologies, which combine two or more imaging modalities (e.g., SPECT/CT, PET/MRI). As such, while very challenging to engineer, instruments for human PET/MRI are now commercially available.

成像技术，如单光子发射计算机断层扫描（SPECT）和正电子发射断层扫描（PET）在人类成像中发挥了宝贵的作用几十年。最近，对所谓的“混合”技术的兴趣已经复苏，该技术联合收割机两种或更多种成像模态（例如，SPECT/CT、PET/MRI）。因此，虽然对工程师来说非常具有挑战性，但用于人类PET/MRI的仪器现在已经可以在市场上买到。